Clinical trial
A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years…
NCT00245479 · Ferring Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00245479 |
|---|---|
| Title | A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis |
| Official title | An Open Label, Multi-national Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis |
| Acronym | DRIP |
| Lead sponsor | Ferring Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Nocturnal Enuresis |
| Intervention type | Drug |
| Interventions | Primary nocturnal enuresis |
| Enrollment | 802 |
| Start date | Apr 1, 2002 |
| Primary completion | Sep 1, 2005 |
| Completion | Nov 1, 2006 |
| First posted | Oct 28, 2005 |
| Last update posted | May 19, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: